Genes in panel
Regions in panel
Prev Next

Intellectual disability

Gene: PHF12

Amber List (moderate evidence)

PHF12 (PHD finger protein 12)
EnsemblGeneIds (GRCh38): ENSG00000109118
EnsemblGeneIds (GRCh37): ENSG00000109118
PHF12 is in 2 panels

2 reviews

Ida Ertmanska (Genomics England Curator)

Green List (high evidence)

Comment on list classification: There are numerous individuals reported in literature in large cohort studies of intellectual disability, ASD, and developmental disorders patients, harbouring heterozygous de novo variants in PHF12. The association between PHF12 and a complex neurodevelopmental disorder was classified as Definitive by the Intellectual Disability and Autism ClinGen Expert Panel (Feb 2025). Based on available evidence this gene should be promoted to Green for Intellectual disability.
Created: 10 Feb 2026, 4:59 p.m. | Last Modified: 10 Feb 2026, 4:59 p.m.
Panel Version: 9.254
The below publication information is taken from ClinGen evidence summary: https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_329aa190-d20e-4f6b-9c85-58242a8a2d33-2025-02-19T110000.000Z?page=1&size=25&search=

Lelieveld SH, et al., 2016, PMID: 27479843
Cohort (Radboud University Medical Center) with unexplained intellectual disability, no detailed clinical information available. Exome seq revealed de novo heterozygous NM_001033561.2(PHF12):c.425C>A (p.Ser142Ter).

Deciphering Developmental Disorders Study, 2017, PMID: 28135719
DDD Study cohort with severe undiagnosed developmental disorders, no detailed clinical information available. Exome seq revealed de novo heterozygous NM_001033561.2(PHF12):c.2645del (p.Pro882GlnfsTer30).

C Yuen RK, et al., 2017, PMID: 28263302
ASD cohort (MSSNG), no detailed clinical information available. Method: Whole genome shotgun sequencing. Het for de novo NM_001033561.2(PHF12):c.1091dup (p.Asn365Ter).

Kaplanis J, et al., 2020, PMID: 33057194
31,058 parent-offspring trios of individuals with developmental disorders.
Cohort (GeneDx) with developmental disorders, no detailed clinical information available: GDX 15850 het for de novo NM_001033561.2(PHF12):c.2360-1G>A
DDD Study cohort: DDD13k.08251 - het for de novo NM_001033561.2(PHF12):c.1970C>G (p.Ser657Ter)
DDD Study cohort: DDD13k.05315 - het for de novo NM_001033561.2(PHF12):c.862C>T (p.Gln288Ter)
Cohort (Radboud University Medical Center) with unexplained intellectual disability: de novo heterozygous NM_001033561.2(PHF12):c.2542-2A>C

Functional evidence:
PMID: 27956701 Graveline et al., 2017 - Phf12 (Pf1) -/- mouse embryos had global growth retardation and impaired development of skeleton, associated skeletal muscle, and brain. They died mid- to late-gestation due to developmental defects including edema and internal hemorrhage. Heterozygous Pf1+/- mice developed normally.

PHF12 is not yet linked to a disease entity in OMIM (accessed 10th Feb 2026). The gene-disease association between PHF12 and AD complex neurodevelopmental disorder (MONDO:0100038) was classified as Definitive by the Intellectual Disability and Autism ClinGen Expert Panel (Feb 2025). Gene2Phenotype rated its association with PHF12-related developmental disorder as Strong.
Created: 10 Feb 2026, 4:42 p.m. | Last Modified: 10 Feb 2026, 4:55 p.m.
Panel Version: 9.253

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
complex neurodevelopmental disorder, MONDO:0100038

Publications

Sophie Ellis (North East & Yorkshire Genomic Laboratory Hub)

Green List (high evidence)

ClinGen Definitive Classification - 02/19/2025
Sources: ClinGen
Created: 13 Jan 2026, 11:32 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Mode of pathogenicity
Other

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
Phenotypes
  • complex neurodevelopmental disorder, MONDO:0100038
Tags
Q1_26_promote_green Q1_26_NHS_review
Clinvar variants
Variants in PHF12
Penetrance
unknown
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

10 Feb 2026, Gel status: 2

Set Phenotypes

Ida Ertmanska (Genomics England Curator)

Phenotypes for gene: PHF12 were changed from to complex neurodevelopmental disorder, MONDO:0100038

10 Feb 2026, Gel status: 2

Set publications

Ida Ertmanska (Genomics England Curator)

Publications for gene: PHF12 were set to

10 Feb 2026, Gel status: 2

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: phf12 has been classified as Amber List (Moderate Evidence).

10 Feb 2026, Gel status: 0

Added Tag

Ida Ertmanska (Genomics England Curator)

Tag Q1_26_NHS_review tag was added to gene: PHF12.

10 Feb 2026, Gel status: 0

Added Tag

Ida Ertmanska (Genomics England Curator)

Tag Q1_26_promote_green tag was added to gene: PHF12.

13 Jan 2026, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set penetrance, Set mode of pathogenicity

Sophie Ellis (North East & Yorkshire Genomic Laboratory Hub)

gene: PHF12 was added gene: PHF12 was added to Intellectual disability. Sources: ClinGen Mode of inheritance for gene: PHF12 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Penetrance for gene: PHF12 were set to unknown Mode of pathogenicity for gene: PHF12 was set to Other Review for gene: PHF12 was set to GREEN gene: PHF12 was marked as current diagnostic